Eric Gaukel
About Eric Gaukel
Eric Gaukel serves as the Associate Director of Drug Disposition and Modeling at Roivant Sciences, where he has worked since 2017. His previous experience includes various roles in drug metabolism and pharmacokinetics at organizations such as Scynexis, Inc. and PPD.
Current Role at Roivant Sciences
Eric Gaukel serves as the Associate Director of Drug Disposition and Modeling at Roivant Sciences. He has held this position since 2017, contributing to the company's efforts in drug development and pharmacokinetics. His role involves overseeing drug disposition strategies and modeling to enhance the efficiency of drug development processes.
Previous Experience at Roivant Sciences
Prior to his current role, Eric Gaukel worked as a Senior Manager in Drug Metabolism and Pharmacokinetics (DMPK) at Roivant Sciences for a period of eight months in 2017. This position allowed him to develop expertise in the pharmacokinetic profiling of drug candidates, supporting the company's research initiatives.
Career Background in Pharmaceutical Industry
Eric Gaukel has extensive experience in the pharmaceutical industry, having worked at various organizations. He began his career at PPD as an Assistant Scientist in 2004 and progressed to roles such as Associate Scientist and Scientist at the same company. He also held positions at GSK and Scynexis, Inc., where he advanced through several roles in DMPK, including Advanced Scientist II and Senior Scientist.
Experience at Scynexis, Inc.
At Scynexis, Inc., Eric Gaukel had a significant tenure from 2007 to 2015, where he held multiple positions in DMPK. He started as a Contractor and progressed to Advanced Scientist I, Advanced Scientist II, and finally Senior Scientist. His work focused on drug metabolism and pharmacokinetics, contributing to the development of new therapeutic agents.
Early Career at PPD
Eric Gaukel's early career included various roles at PPD, where he worked from 2004 to 2007. He started as an Assistant Scientist and advanced to Associate Scientist and Scientist. His experience at PPD provided a foundation in drug development and research methodologies.